HealthKart Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
1,427
- Latest Deal Type
-
2ndary - Private
- Latest Deal Amount
-
$153M
- Investors
-
11
HealthKart General Information
Description
Operator of a health and nutritional supplements company intended for people of all age groups.The company offers a wide range of products including protein supplements, weight loss products, hair kits, foods, and drinks, enabling customers with products that are in line with all their fitness needs.
Contact Information
Website
www.healthkart.comCorporate Office
- 1st Floor, Tower B, The Presidency, Anamika Enclave, Sector 14
- Mehrauli-Gurgaon Road, Opposite Govt. Girls College
- Gurgaon, 122001
- India
Corporate Office
- 1st Floor, Tower B, The Presidency, Anamika Enclave, Sector 14
- Mehrauli-Gurgaon Road, Opposite Govt. Girls College
- Gurgaon, 122001
- India
HealthKart Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Secondary Transaction - Private | 18-Nov-2024 | $153M | Completed | Profitable | ||
| 11. Secondary Transaction - Private | 05-Apr-2024 | Cancelled | Generating Revenue | |||
| 10. Later Stage VC (Series H) | 01-Dec-2022 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series G) | 27-Jun-2022 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series G) | 09-May-2019 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series F) | 01-Jul-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series E1) | 26-Jul-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series E) | 01-Aug-2016 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 01-Apr-2013 | $14M | $26.5M | Completed | Startup | |
| 3. Early Stage VC (Series B) | 11-Jan-2012 | $7.5M | $12.5M | Completed | Startup |
HealthKart Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Series H CCPS | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Series G1 CCPS | ||||||||
| Series G | ||||||||
| Series F | ||||||||
| Series E1 | ||||||||
| Ordinary | 744 | $0.012260 | $12.26 | $12.26 | 1x | $12.26 | 0.04% | |
| Series E | 198,120 | $0.122598 | $49.5 | $49.5 | 1x | $49.5 | 10.94% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
HealthKart Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
HealthKart Patents
HealthKart Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250099527-A1 | Potentiated ashwagandha roots compound with improved efficacy | Pending | 26-Sep-2023 | ||
| US-12693282-B2 | Determining protein content of protein supplements and determining genuine or counterfeit protein supplements with a novel consumer friendly kit | Active | 04-Aug-2021 | ||
| US-20230040075-A1 | Determining protein content of protein supplements and determining genuine or counterfeit protein supplements with a novel consumer friendly kit | Active | 04-Aug-2021 | ||
| US-12220447-B2 | Proteolytic enzyme composition | Active | 07-Feb-2019 | ||
| US-12472242-B2 | Proteolytic enzyme composition | Active | 07-Feb-2019 | A61K38/465 |
HealthKart Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
HealthKart Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ChrysCapital | PE/Buyout | Minority | ||
| Motilal Oswal Real Estate Investment Advisors | Real Estate | Minority | ||
| Neo Group | Corporation | Minority | ||
| A91 Partners | Venture Capital | Minority | ||
| Elev8 Venture Partners | Growth/Expansion | Minority |
HealthKart Investments & Acquisitions (3)
HealthKart’s most recent deal was a Seed Round with Blaer for . The deal was made on 07-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Blaer | 07-Jun-2021 | Seed Round | Automotive | ||
| Medd | 05-Jul-2016 | Merger/Acquisition | Other Healthcare Services | ||
| MadeInHealth | 21-May-2012 | Merger/Acquisition | Specialty Retail |
HealthKart FAQs
-
When was HealthKart founded?
HealthKart was founded in 2011.
-
Where is HealthKart headquartered?
HealthKart is headquartered in Gurgaon, India.
-
What is the size of HealthKart?
HealthKart has 1,427 total employees.
-
What industry is HealthKart in?
HealthKart’s primary industry is Specialty Retail.
-
Is HealthKart a private or public company?
HealthKart is a Private company.
-
What is the current valuation of HealthKart?
The current valuation of HealthKart is .
-
What is HealthKart’s current revenue?
The current revenue for HealthKart is .
-
How much funding has HealthKart raised over time?
HealthKart has raised $150M.
-
Who are HealthKart’s investors?
ChrysCapital, Motilal Oswal Real Estate Investment Advisors, Neo Group, A91 Partners, and Elev8 Venture Partners are 5 of 11 investors who have invested in HealthKart.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
